Log in
Enquire now

List of Ribon Therapeutics patents

List of Ribon Therapeutics patents
List of Gradalis, Inc. patents
List of Rigel Pharmaceuticals patents
List of Twist Bioscience patents
List of companies in Block Dream Fund's investment portfolio
List of Gatik patents
Patents where
Current Assignee
Name
is
Ribon TherapeuticsRibon Therapeutics
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 11293927 Screening methods for PARP modulators

Patent 11293927 was granted and assigned to Ribon Therapeutics on April, 2022 by the United States Patent and Trademark Office.

Ribon Therapeutics
Ribon Therapeutics
Ribon Therapeutics
Ribon Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
11293927
April 5, 2022
‌
US Patent 11008308 Quinazolinones as PARP14 inhibitors

Patent 11008308 was granted and assigned to Ribon Therapeutics on May, 2021 by the United States Patent and Trademark Office.

Ribon Therapeutics
Ribon Therapeutics
Ribon Therapeutics
Ribon Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
11008308
May 18, 2021
‌
US Patent 11566020 Pyridazinones as PARP7 inhibitors

Ribon Therapeutics
Ribon Therapeutics
Ribon Therapeutics
Ribon Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
11566020
January 31, 2023
‌
US Patent 11535621 Heterobicyclic amides as inhibitors of CD38

Ribon Therapeutics
Ribon Therapeutics
Ribon Therapeutics
Ribon Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
11535621
December 27, 2022
‌
US Patent 10562891 Quinazolinones as PARP14 inhibitors

Patent 10562891 was granted and assigned to Ribon Therapeutics on February, 2020 by the United States Patent and Trademark Office.

Ribon Therapeutics
Ribon Therapeutics
Ribon Therapeutics
Ribon Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10562891
February 18, 2020
‌
US Patent 11014913 Pyridazinones as PARP7 inhibitors

Patent 11014913 was granted and assigned to Ribon Therapeutics on May, 2021 by the United States Patent and Trademark Office.

Ribon Therapeutics
Ribon Therapeutics
Ribon Therapeutics
Ribon Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
11014913
May 25, 2021
‌
US Patent 10550105 Pyridazinones as PARP7 inhibitors

Patent 10550105 was granted and assigned to Ribon Therapeutics on February, 2020 by the United States Patent and Trademark Office.

Ribon Therapeutics
Ribon Therapeutics
Ribon Therapeutics
Ribon Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10550105
February 4, 2020
‌
US Patent 10870641 Pyridazinones as PARP7 inhibitors

Ribon Therapeutics
Ribon Therapeutics
Ribon Therapeutics
Ribon Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10870641
December 22, 2020
‌
US Patent 11958837 Quinazolinones as PARP14 inhibitors

Patent 11958837 was granted and assigned to Ribon Therapeutics on April, 2024 by the United States Patent and Trademark Office.

Ribon Therapeutics
Ribon Therapeutics
Ribon Therapeutics
Ribon Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
11958837
April 16, 2024
‌
US Patent 11691969 Pyridazinones as PARP7 inhibtors

Ribon Therapeutics
Ribon Therapeutics
Ribon Therapeutics
Ribon Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
11691969
July 4, 2023
10 results
0 selected
10 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us